BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Apimostinel readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Apimostinel\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06400121-870@assetmemo.bio
DTSTAMP:20261121T004006Z
DTSTART;VALUE=DATE:20290301
DTEND;VALUE=DATE:20290302
SUMMARY:Apimostinel: Phase 2 readout est. (NCT06400121)
DESCRIPTION:Apimostinel\, phase 2.\nStudy: Apimostinel + Automated Neurocog
 nitive Training for Depression\nEstimated primary completion: 1 March 2029
 . This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, a
 nd it can move.\nDrug page: https://assetmemo.bio/drug/apimostinel#upcomin
 g-events\nRegistry record: https://clinicaltrials.gov/study/NCT06400121
URL:https://assetmemo.bio/drug/apimostinel#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
